Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors
Status:
Recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to gather information on the safety and effectiveness of
Intrarosa®, also known as Dehydroepiandrosterone (DHEA), and prasterone. By doing this study,
the investigators hope to learn if Intrarosa® can improve vaginal discomfort. Participants
will be assigned to one of two groups. One group will use Intrarosa® once a day. The other
group will use Replens™ two times a week.
Phase:
Phase 2
Details
Lead Sponsor:
University of Arkansas
Collaborator:
AMAG Pharmaceuticals, Inc.
Treatments:
Calcium polycarbophil Dehydroepiandrosterone Glycerol Mineral Oil Psyllium